J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

A more recent version of this article appeared on September 1, 2005

Papers In Press, published online ahead of print June 16, 2005
J. Lipid Res., doi:10.1194/jlr.M500151-JLR200
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
M500151-JLR200v1
46/9/1983    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kleinfeld, A. M.
Right arrow Articles by Okada, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kleinfeld, A. M.
Right arrow Articles by Okada, C.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted on April 19, 2005
Revised on June 9, 2005
Accepted on June 15, 2005

Free fatty acid release from human breast cancer tissue inhibits cytotoxic T lymphocyte- mediated killing

Alan M. Kleinfeld and Clifford Okada

Membrane Biology, Torrey Pines Institute for Molecular Studies, San Diego, CA 92121

Corresponding Author: akleinfeld{at}tpims.org

Immune-mediated anti-tumor activities confront a variety of tumor-mediated defense mechanisms. Here we describe a new mechanism involving FFA that may allow breast cancer to evade immune clearance. We determined the IC50 at which unbound FFA (FFAu) inhibit murine cytotoxic T lymphocyte (CTL)-mediated killing, to assess the physiologic relevance of this phenomenon. We find that the IC50 for unbound oleate is 125 ± 30 nM, about 200 fold larger than normal plasma levels. FFA inhibition may, however, play an important role in breast cancer because we find that large quantities of FFA are released constitutively into the media surrounding samples of human breast cancer but not normal or benign tissue. [FFAu] rose to at least 25 nM in 20 of 22 cancer tissue samples and exceeded 100 nM in 11 patients. Media from these samples inhibited CTL-killing. Extrapolation from our in vitro conditions suggests that for tumor interstitial fluid in vivo [FFAu] may be 300 fold larger than we observe in vitro. Although breast cancer release of FFA may suppress effector cell anti-tumor activity, strategies that reduce interstitial [FFAu] may significantly improve anti-tumor immune therapies.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Lipid Res.Home page
S. R. Shaikh and M. Edidin
Immunosuppressive effects of polyunsaturated fatty acids on antigen presentation by human leukocyte antigen class I molecules
J. Lipid Res., January 1, 2007; 48(1): 127 - 138.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
S. Yakar, N. P. Nunez, P. Pennisi, P. Brodt, H. Sun, L. Fallavollita, H. Zhao, L. Scavo, R. Novosyadlyy, N. Kurshan, et al.
Increased Tumor Growth in Mice with Diet-Induced Obesity: Impact of Ovarian Hormones
Endocrinology, December 1, 2006; 147(12): 5826 - 5834.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
E. Shumilina, N. Klocker, G. Korniychuk, M. Rapedius, F. Lang, and T. Baukrowitz
Cytoplasmic accumulation of long-chain coenzyme A esters activates KATP and inhibits Kir2.1 channels
J. Physiol., September 1, 2006; 575(2): 433 - 442.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.